CAPSTONE THERAPEUTICS CORP COM STK (DE)
CAPS
CAPS was delisted on the 20th of July, 2011.
2 hedge funds and large institutions have $4K invested in CAPSTONE THERAPEUTICS CORP COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
20% less capital invested
Capital invested by funds: $5K → $4K (-$1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
-$1.32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
EARNEST Partners
Atlanta,
Georgia
| $3K | -$1.32K | -4,900 | -31% |
|
|
MWP
2
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
| $1K | – | – | – |
|
CAPS Hedge Fund Activity: Q1 2014 in Review
2 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in CAPSTONE THERAPEUTICS CORP COM STK (DE) (CAPS) for Q1 2014, worth a combined $4K — down 20% from $5K a quarter earlier.
Fund positioning in CAPS was balanced in Q1 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was EARNEST Partners, cutting an estimated $1.32K.
- 2 institutional investors held CAPSTONE THERAPEUTICS CORP COM STK (DE) (CAPS) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $4K of CAPSTONE THERAPEUTICS CORP COM STK (DE) stock for Q1 2014, down 20% quarter-over-quarter.
- 0 funds opened new CAPSTONE THERAPEUTICS CORP COM STK (DE) positions in Q1 2014 and 0 closed out.
- The largest CAPSTONE THERAPEUTICS CORP COM STK (DE) seller in Q1 2014 was EARNEST Partners, an estimated $1.32K sold.
Based on aggregated 13F filings for Q1 2014.